Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17169668 | 0.97 | THRB (0.33) | THRB | |
| SCHEMBL45482 | 0.89 | THRB (0.36) | THRB | |
| SCHEMBL14367065 | 0.89 | THRB (0.30) | THRB | |
| SCHEMBL1115998 | 0.88 | THRB (0.32) | THRB | |
| SCHEMBL13791402 | 0.87 | — | — | |
| SCHEMBL21291961 | 0.86 | THRB (0.35) | THRB | |
| SCHEMBL7113288 | 0.86 | THRB (0.35) | THRB | |
| SCHEMBL17460095 | 0.86 | THRB (0.35) | THRB | |
| SCHEMBL13616508 | 0.86 | THRB (0.35) | THRB | |
| SCHEMBL8353291 | 0.84 | ALDH1A1 (0.38) | THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9169184-B2 | Method for producing ditrimethylolpropane | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2015-10-27 | — | — | US | disclosed |
| CN-103467252-B | Method for increasing purity of di-trimethylolpropane | BAICHUAN CHEMICAL RUGAO CO LTD | 2014-12-24 | — | — | CN | disclosed |
| CN-103467252-A | Method for increasing purity of di-trimethylolpropane | BAICHUAN CHEMICAL RUGAO CO LTD | 2013-12-25 | — | — | CN | disclosed |
| US-8492596-B2 | Process for production of ditrimethylolpropane | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2013-07-23 | — | — | US | disclosed |
| US-20130184497-A1 | METHOD FOR PRODUCING DITRIMETHYLOLPROPANE | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2013-07-18 | — | — | US | disclosed |
| US-20100240931-A1 | PROCESS FOR PRODUCTION OF DITRIMETHYLOLPROPANE | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2010-09-23 | — | — | US | disclosed |
| US-7211701-B2 | Preparation of trimethylolpropane | LANXESS DEUTSCHLAND GMBH (DE) | 2007-05-01 | — | — | US | disclosed |
| JP-2006193450-A | POLYOL (METH)ACRYLATE | MITSUBISHI GAS CHEM CO INC | 2006-07-27 | — | — | JP | disclosed |
| CN-1217896-C | Treatment of composition comprising trimetlylohalkane bis-monolinear formal | CELANESE INT CORP (US) | 2005-09-07 | — | — | CN | disclosed |
| US-20030139631-A1 | Having a low APHA colour number by reacting n-butyraldehyde and/or 2,2-dimethylolbutyraldehyde with formaldehyde in the presence of an inorganic base, fractionally distilling | LANXESS DEUTSCHLAND GMBH (DE) | 2003-07-24 | — | — | US | disclosed |
| EP-1323698-A2 | Process for the preparation of trimethylolpropane | Bayer Aktiengesellschaft (DE) | 2003-07-02 | — | — | EP | disclosed |
| CN-1353682-A | Treatment of composition comprising trimetlylohalkane bis-monolinear formal | CELANESE INT CORP (US) | 2002-06-12 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130184497-A1 | METHOD FOR PRODUCING DITRIMETHYLOLPROPANE | TPR, TRRAP, MTTP | THRB 309/4885 |
| US-20100240931-A1 | PROCESS FOR PRODUCTION OF DITRIMETHYLOLPROPANE | ESD, TET1, TFB2M | THRB 637/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.